Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “Prexasertib, a cell cycle checkpoint kinase 1 inhibitor, in BRCA mutant recurrent high-grade serous ovarian cancer (HGSOC): A proof-of-concept single arm phase II study.”.
Daniel An, Ann McCoy, Elise C. Kohn, Christina M. Annunziata, Kathryn Trewhitt +4 more
Nicole Houston, Stan Lipkowitz, Jung Min Lee, Alexandra Dos Santos Zimmer, Farah Zia +9 more
Seth M. Steinberg, DeeDee Kay Smart, Mark R. Gilbert, Terri S. Armstrong, Eric Burton +9 more